Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.6K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Scientific computing in an AI world.

Science (New York, N.Y.)·2026
Same author

Insights from farming Macrocystis pyrifera offshore: phenotypic analysis, genome-wide association studies, genomic selection.

Heredity·2026
Same author

Ropeginterferon alfa-2b-njft treatment in essential thrombocythemia across different driver mutations: results from a North American, single-arm, multicentre study (EXCEED-ET).

Lancet regional health. Americas·2026
Same author

Real-world heterogeneity in the prognostic value of pre-transplant flow cytometry measurable residual disease in acute myeloid leukemia in first complete remission: CIBMTR analysis.

Haematologica·2026
Same author

Right aortic arch and double arch assessed by prenatal echocardiography: a population-based study.

European heart journal·2026
Same author

Feasibility and Acceptability of a Breastfeeding Support Intervention Among Mothers of Infants Under Six Months Old Discharged From Malnutrition Treatment in Kilifi County.

Maternal & child nutrition·2026
Same journal

BRAF Alterations in Chronic Lymphocytic Leukemia: Genomic Landscape, Co-Mutation Patterns, and Clinical Relevance.

Current hematologic malignancy reports·2026
Same journal

Targeting the BCR::ABL1 Kinase: Advances Beyond Imatinib in Chronic Myeloid Leukemia.

Current hematologic malignancy reports·2026
Same journal

Germline DDX41 Variants: Current Understanding and Future Directions.

Current hematologic malignancy reports·2026
Same journal

Clonal Signatures of Telomere Biology Disorders.

Current hematologic malignancy reports·2026
Same journal

Molecular Pathogenesis and Targeted Therapies for Myeloproliferative Hypereosinophilic Neoplasms.

Current hematologic malignancy reports·2026
Same journal

The Intricate Dance Between Inflammation and Myeloproliferative Neoplasms: From Origins to Outcomes.

Current hematologic malignancy reports·2026
查看所有相关文章

相关实验视频

Updated: Jul 9, 2025

Tracking Bispecific Antibody-Induced T Cell Trafficking Using Luciferase-Transduced Human T Cells
10:19

Tracking Bispecific Antibody-Induced T Cell Trafficking Using Luciferase-Transduced Human T Cells

Published on: May 12, 2023

1.3K

在实践中使用Blinatumomab.

Jeffrey Lantz1, Natalie Pham2, Caroline Jones3

  • 1Division of Hematology and Oncology, Department of Medicine, University of Virginia, Charlottesville, VA, USA.

Current hematologic malignancy reports
|December 7, 2023
PubMed
概括
此摘要是机器生成的。

布利纳图莫马布可以改善B细胞急性淋巴细胞白血病 (ALL) 的存活率,即使是在前线治疗中. 这种双特异性T细胞吸引剂 (BiTE) 疗法需要由多学科团队进行仔细管理,以减轻诸如细胞因子释放综合征和神经毒性等副作用.

关键词:
急性淋巴细胞白血病 (Acute Lymphoblastic Leukemia) 是一种急性淋巴细胞白血病.B细胞急性淋巴细胞白血病.双TE,CD19阳性B细胞布莱纳图莫马巴姆是什么意思眼细胞是如何形成的复发性/耐药性急性淋巴细胞白血病.

更多相关视频

Flow Cytometry-based Assay for the Monitoring of NK Cell Functions
08:17

Flow Cytometry-based Assay for the Monitoring of NK Cell Functions

Published on: October 30, 2016

21.1K
Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice
05:32

Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice

Published on: January 7, 2019

6.9K

相关实验视频

Last Updated: Jul 9, 2025

Tracking Bispecific Antibody-Induced T Cell Trafficking Using Luciferase-Transduced Human T Cells
10:19

Tracking Bispecific Antibody-Induced T Cell Trafficking Using Luciferase-Transduced Human T Cells

Published on: May 12, 2023

1.3K
Flow Cytometry-based Assay for the Monitoring of NK Cell Functions
08:17

Flow Cytometry-based Assay for the Monitoring of NK Cell Functions

Published on: October 30, 2016

21.1K
Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice
05:32

Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice

Published on: January 7, 2019

6.9K

科学领域:

  • 血液瘤学 血液瘤学
  • 免疫治疗是一种免疫疗法.
  • 临床试验分析

背景情况:

  • 成人的急性淋巴细胞白血病 (ALL),特别是B细胞ALL,尽管进行了密集治疗,但其生存结果具有挑战性.
  • 新型向疗法对于提高B细胞ALL管理的疗效和降低毒性至关重要.

研究的目的:

  • 评估blinatumomab在治疗B细胞ALL中的有效性和安全性.
  • 提供关于管理布利纳图马布治疗的指导,考虑到其不良事件和管理.

主要方法:

  • 对BLINATUMOMAB在B细胞ALL中的疗效和不良事件的现有数据进行系统审查.
  • 综合关于其在复发/耐火和前线环境中的使用的证据.
  • 针对多学科团队管理的指导开发.

主要成果:

  • 布利纳莫马布在B细胞ALL中表现出有效性,越来越多的证据支持其在前线治疗中使用.
  • 潜在的严重副作用包括细胞因子释放综合征和神经毒性,需要谨慎监测.
  • 多学科团队的协调护理有助于对不良事件的早期识别和干预.

结论:

  • 布利纳图莫马布是对B细胞ALL的一种有前途的免疫疗法,改善了生存结果.
  • 安全和有效的管理依赖于多学科的方法来管理潜在的毒性.
  • 需要进一步的研究来探索blinatumomab在各种治疗线和社区环境中.